MPOS — Micropos Medical AB (publ) Income Statement
0.000.00%
Last trade - 00:00- SEK291.37m
- SEK270.30m
- SEK3.82m
Annual income statement for Micropos Medical AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Interim Report | ARS | ARS | ARS | ARS |
| Standards: | — | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3.7 | 3.27 | 1.09 | 1.64 | 3.82 |
| Cost of Revenue | |||||
| Gross Profit | 4.61 | 2.06 | 0.905 | 1.42 | 2.84 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 15.9 | 17.7 | 19.6 | 25.5 | 26 |
| Operating Profit | -12.2 | -14.4 | -18.5 | -23.9 | -22.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -12.3 | -14.4 | -18.6 | -23.5 | -21.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -12.3 | -14.4 | -18.6 | -23.5 | -21.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -12.3 | -14.4 | -18.6 | -23.5 | -21.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -12.3 | -14.4 | -18.6 | -23.5 | -21.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.108 | -0.115 | -0.148 | -0.168 | -0.139 |
| Dividends per Share |